BRCA1 and neoplasm: Tumor profiling revealed the same BRCA1 variant (VAF 56%) plus a pathogenic TP53 mutation (c.730G>T, p.Gly244Cys; VAF 32%), without <i>BRCA1</i> loss of heterozygosity.